1-phenyl-2-palmitoylamino-3-morpholino-1-propanol has been researched along with Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted in 1 studies
1-phenyl-2-palmitoylamino-3-morpholino-1-propanol: a sphingolipid analog; inhibits the enzyme activity in infected erythrocytes
N-[1-hydroxy-3-(morpholin-4-yl)-1-phenylpropan-2-yl]hexadecanamide : A fatty amide resulting from the formal condensation of palmitic acid with the primary amino group of 2-amino-3-(morpholin-4-yl)-1-phenylpropan-1-ol.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sakamoto, H | 1 |
| Okamoto, K | 1 |
| Aoki, M | 1 |
| Kato, H | 1 |
| Katsume, A | 1 |
| Ohta, A | 1 |
| Tsukuda, T | 1 |
| Shimma, N | 1 |
| Aoki, Y | 1 |
| Arisawa, M | 1 |
| Kohara, M | 1 |
| Sudoh, M | 1 |
1 other study available for 1-phenyl-2-palmitoylamino-3-morpholino-1-propanol and Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted
| Article | Year |
|---|---|
Host sphingolipid biosynthesis as a target for hepatitis C virus therapy.
Topics: Cell Line; Citrates; Hepacivirus; Hepatitis C; Humans; Membrane Microdomains; Phenylpropionates; Pro | 2005 |